alphaRep-HR2 entry inhibitors and a non-antigenic test for the treatment and diagnosis of COVID-19 - Texts

Home
Main Navigation
Content
Search
Help

Font Standard Bold
Login

Research unit

INNOSUISSE

Project number

54121.1 IP-LS

Project title

alphaRep-HR2 entry inhibitors and a non-antigenic test for the treatment and diagnosis of COVID-19

Texts for this project

	German	French	Italian	English
Short description		-	-
Abstract		-	-	-

Inserted texts

Category	Text
Short description (German)	alphaRep-HR2 entry inhibitors and a non-antigenic test for the treatment and diagnosis of COVID-19
Short description (English)	alphaRep-HR2 entry inhibitors and a non-antigenic test for the treatment and diagnosis of COVID-19
Abstract (German)	The SARS-CoV2 pandemic is a major health, economic and societal issue worldwide. Despite the advent of vaccines, novel therapeutic and diagnostic options are needed. Here, we wish to use S artificial nanoligands to develop novel potent entry inhibitors and a non-antigenic test for massive screening.